Abstract
Human papillomavirus (HPV) is associated with various human diseases, including cancer, and developing vaccines is a cost-efficient strategy to prevent HPV-related disease. The major capsid protein L1, which an increasing number of studies have confirmed is typically expressed early in infection, is a promising antigen for such a vaccine, although the E6 and E7 proteins have been characterized more extensively. Thus, the L1 gene from HPV16 was inserted into a recombinant vector, AdHu5, and MVA viral vectors, and administered by prime-boost immunization. Virus-like particles were used as control antigens. Our results indicate that prime-boost immunization with heterologous vaccines induced robust and sustained cellular and humoral response specific to HPV16 L1. In particular, sera obtained from mice immunized with DNA + DNA + Ad + MVA had excellent antitumor activity in vivo. However, the data also confirm that virus-like particles can only elicit low levels cellular immunity and not be long-lasting, and are therefore unsuitable for treatment of existing HPV infections.
References
Feb 1, 1992·Human Pathology·M H StolerT R Broker
Apr 1, 1995·The Journal of Infectious Diseases·M EvanderG Wadell
Oct 30, 1998·Virology·M L De BruijnW M Kast
Mar 29, 2003·Journal of Virology·Peter OhlschlägerLutz Gissmann
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·A Reyes-Sandoval, H C J Ertl
May 12, 2004·Lancet·M L Gillison, D R Lowy
May 26, 2005·Virology·Mark SchiffmanRobert D Burk
Sep 24, 2005·Vaccine·Inese CebereTomás Hanke
Apr 13, 2007·Journal of Virology·Kimberly McCoyHildegund C J Ertl
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Allan HildesheimUNKNOWN Costa Rican HPV Vaccine Trial Group
Nov 6, 2007·Current Gene Therapy·Pedro R LowensteinMaria G Castro
Apr 24, 2009·Journal of Virology·Stefania BelloneAlessandro D Santin
Sep 11, 2012·BMC Cancer·Margaret A StanleyPeter K C Goon
Mar 15, 2013·Scientific Reports·Teresa LambeSarah C Gilbert
Nov 10, 2013·PloS One·Muhammed O AfolabiKatie L Flanagan
Sep 10, 2014·Head & Neck·John M KaczmarGregory S Weinstein
Oct 3, 2014·Human Gene Therapy·Ricardo RosalesFreddy Villarreal
Oct 23, 2014·The Journal of Infectious Diseases·Susanne H HodgsonAdrian V S Hill
Dec 3, 2014·La Presse médicale·Silvia de SanjoséLaia Alemany
Dec 3, 2014·Oral Oncology·Wojciech K MydlarzJeremy D Richmon